London-based healthtech startup Chiron has raised £900,000 in a seed investment round to scale its AI-powered patient management platform. Specialist healthcare investor THENA Capital led the financing round, with further backing provided by Arāya Ventures.
The fresh injection of capital is earmarked to drive Chiron’s deployment across the UK healthcare ecosystem, specifically targeting NHS Integrated Care Boards, Primary Care Networks and integrated neighbourhood health teams. Additionally, the funds will be used to establish the commercial and regulatory foundations required for the company’s future expansion into the United States market.
Chiron’s software functions as an intelligent layer designed to shift healthcare from a reactive, episodic model to a continuous feedback loop. By pooling electronic health records, patient-reported outcomes, data from wearable devices and AI analytics, the platform builds adaptive self-management plans for individuals with chronic conditions. Early trials involving chronic pain patients conducted alongside Fibromyalgia UK revealed a 31% improvement in clinical outcomes. The platform holds UKCA Class I medical device status and is fully compliant with GDPR, HIPAA and DTAC frameworks.
Carron Manning, CEO and Co-founder, Chiron, said: “As a healthcare professional, I saw first-hand how transformative it is when people are given the right tools, confidence and insights to find what works best for them. We also know from research that engaged, activated patients consistently demonstrate better outcomes, lower utilisation, and sustained adherence across long-term condition management. The future of healthcare therefore lies in empowering people to take an active role in their own health, supported by an intelligent, integrated and data-driven self-management layer that works alongside clinicians and medical care – not instead of them. This investment enables us to scale that vision – delivering personalised care beyond the clinic, enabling every person to feel confident to manage their own health, while giving clinicians the insight they need to improve efficacy, reduce demand, and extend their reach.”
The business was originally spun out of Founders Factory with corporate backing from Reckitt. It has previously secured financial backing from Innovate UK and the Medical Research Council.
Tatum Getty, Founding Partner, THENA Capital, said: “Healthcare systems are increasingly recognising that better outcomes depend on supporting patients beyond traditional clinical settings. Chiron’s team has built an impressive platform that combines robust clinical evidence, advanced AI and deep integration into existing healthcare pathways. At THENA Capital, we believe Chiron is exceptionally well positioned to become a global leader in patient activation and digitally enabled self-management, and we are delighted to lead this investment to vastly improve the patient experience for chronic conditions.”
Rupa Popat, Founder and Managing Partner, Arāya Ventures, said: “At Arāya Ventures, we back exceptional founders using AI to solve large, complex problems across sectors including healthcare. Chiron is building technology that will reshape preventative care through more personalised and accessible healthcare whilst reducing pressure on health systems. We are excited to support the team as they scale across the UK and internationally.”
The company’s founding team includes Chief Operating Officer Dr Karen Lawson, formerly of Nike Digital, and Chief Technology Officer Davide Crescenzi.
